DCF — KALEIDA HEALTH
Enterprise Value: $-2.0B
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-2.0B
Enterprise Value
$-626.3M
PV of Cash Flows
$-1.3B
PV of Terminal Value
$-2.1B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $1.4B | $-118.3M | -8.0% | $-178.7M | $-162.4M |
| Year 2 | $1.5B | $-107.2M | -7.0% | $-169.3M | $-140.0M |
| Year 3 | $1.5B | $-95.3M | -6.0% | $-159.3M | $-119.7M |
| Year 4 | $1.6B | $-90.4M | -6.0% | $-156.3M | $-106.8M |
| Year 5 | $1.6B | $-89.1M | -6.0% | $-157.0M | $-97.5M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-2.0B. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$1.4B
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.08804713536637324
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5